Brian Quigley

Brian Quigley is the Chief Executive Officer for Qnovia, a California venture-backed health technology company focused on commercializing proprietary inhalation device technologies to improve patient outcomes.

Qnovia is currently engaged with FDA CEDR to pursue a combination product authorization as the first inhalable prescription smoking cessation therapy.

Brian Quigley has 25 years of marketing, regulatory, operations and general management experience for public companies, private equity backed businesses, and venture backed businesses. He developed a focus on inhalation devices through his time in tobacco, which gave him an understanding of the risks of tobacco use, the opportunity to reduce risks for smokers, and the current generation of technologies.

Prior to Qnovia, Brian Quigley spent 16 years at Altria Group, with seven years as President & CEO for Altria’s Smokeless and Innovative Products/Vapor Businesses. Brian has also been an active venture investor in both the cannabis and alcohol spaces, and he sits on the boards of Mustgrow Biologics and Belle Isle Craft Spirits. He lives in Richmond, VA, with his wife Amy and three sons.

Areas of Expertise

Strategic Planning | P&L Management | Innovation/Product Strategy | Brand/Portfolio Strategy Revenue Growth Management/Pricing Strategy | Manufacturing/Supply Chain | Regulatory Strategy/Change Management | Investor Communications/Engagement
Board of Directors Engagement | Inclusive/Inspiring Leadership

Brian Quigley is also featured on our premiere Features Page.